5 Lymphoma Clinical Trials in Providence, RI (2026)

Q: How do I join a clinical trial in Providence?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you.

Recruiting Lymphoma Studies in Providence

NCT06090539Recruiting

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary biological and clinical activity of BMS-986458, a bifunctional cereblon-dependent ligand-directed degrad...

Providence, RIPHASE1460 participantsBristol-Myers Squibb

View Study Details

NCT06564038Recruiting

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

The purpose of this study is to assess the safety and efficacy of AZD0486 administered as monotherapy or in combination with other anticancer agents in participants with hematological malignancies....

Providence, RIPHASE1408 participantsAstraZeneca

View Study Details

NCT07284433Recruiting

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

This study is testing Allo-QuadCAR01-T, a new off-the-shelf CAR-T therapy for people with hard-to-treat B-cell cancers. Unlike current CAR-T treatments that use a patient's own cells, this therapy use...

Providence, RIPHASE1178 participantsAvenCell Therapeutics, Inc.

View Study Details

NCT04792502Recruiting

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

BrUOG-401 is a prospective, single-arm, phase 2 trial of first-line therapy in adult patients with previously untreated FL or MZL. All patients will be assigned the same initial treatment plan, modifi...

Providence, RIPHASE252 participantsBrown University

View Study Details

NCT06607549Recruiting

Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)

The purpose of this clinical trial is to learn if drugs loncastuximab tesirine and rituximab (lonca-R) after stereotactic radiosurgery are safe and effective for treatment of central nervous system ly...

Providence, RIPHASE112 participantsUniversity of Utah

View Study Details

About Lymphoma Clinical Trials in Providence

Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.

There are currently 5 lymphoma clinical trials recruiting participants in Providence, RI. These studies are seeking a combined 1,110 participants. Research is being sponsored by Bristol-Myers Squibb, AstraZeneca, AvenCell Therapeutics, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lymphoma Clinical Trials in Providence — FAQ

Are there lymphoma clinical trials in Providence?

Yes, there are 5 lymphoma clinical trials currently recruiting in Providence, RI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Providence?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you about next steps.

Are clinical trials in Providence free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Providence studies also compensate for your time and travel.

What lymphoma treatments are being tested?

The 5 active trials in Providence are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.

Data updated July 19, 2026 from ClinicalTrials.gov